The global anti-biofilm wound dressing market size is expected to reach USD 1.48 billion by 2030, registering a CAGR of 9.6% from 2023 to 2030, according to a new report by Grand View Research, Inc. The rising incidence of Hospital Acquired Infections (HAIs), the growing prevalence of chronic diseases, and the increasing number of burn cases are the key driving factors for the market.
Increasing the prevalence of chronic diseases across the globe is anticipated to drive the market. For instance, as per the International Diabetes Federation, the global prevalence of diabetes is expected to increase from 366.0 million in 2011 to 552.0 million by 2030. Since prolonged diabetes leads to diabetic foot ulcers, thus, the rising prevalence of diabetes is expected to render a positive impact on market growth over the forecast period. The anti-biofilm wound dressing is very much effective in healing chronic injuries, thus, this factor is expected to propel the demand for the product. Furthermore, the increasing geriatric population across the globe is also anticipated to surge the market growth. For instance, as per the World Health Organization (WHO), the global geriatric population is anticipated to rise from 90.0 million in 2016 to 2.0 billion by 2050. Since the geriatric population is prone to chronic diseases and ulcers, thus growing geriatric population is also expected to surge in market growth.
Increasing cases of accidents and trauma such as burns are expected to contribute to market growth. Traumatic events are most common in low and middle-income countries in comparison to high-income countries. Around 50.00% of people globally are exposed to fire-related traumas. For instance, as per the WHO, over 1,000,000 people are registered, annually, as moderately or severely burnt. Therefore, such an increase in the number of burn cases is projected to boost the demand for the products, thereby propelling the market growth over the forecast period.
Request a free sample copy or view the report summary: Anti-biofilm Wound Dressing Market Report
In terms of revenue, the chemical mode of the mechanism segment held the largest share in 2019. An increase in the use of silver anti-biofilm wound dressing in chronic and acute injuries is the major factor driving the segment
The acute wounds segment held the largest market share in 2019 owing to the rising number of surgical procedures across the globe
Asia Pacific is anticipated to witness the fastest growth over the forecast period owing to the rising number of surgeries and the presence of many local players.
Grand View Research has segmented the global anti-biofilm wound dressing market based on mode of mechanism, application, end-use, and region:
Anti-biofilm Wound Dressing Mode of Mechanism Outlook (Revenue, USD Million, 2018 - 2030)
Physical
Manual Debridement
Pulse Electrical Field
Ultrasound Debridement
Chemical
Ionic Silver
Iodine
EDTA
Others
Biological
Dispersin B
Lactoferrin
Bacteriophage
Others
Anti-biofilm Wound Dressing Application Outlook (Revenue, USD Million, 2018 - 2030)
Chronic Wounds
Diabetic Foot Ulcers
Pressure Ulcers
Venous Leg Ulcers
Others
Acute Wounds
Surgical & Traumatic Wounds
Burn Wounds
Anti-biofilm Wound Dressing End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Specialty Clinics
Home Healthcare
Others
Anti-biofilm Wound Dressing Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Sweden
Denmark
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in Anti-biofilm Wound Dressing Market
ConvaTec Inc.
Smith & Nephew PLC
Urgo Medical
Coloplast
3M
Mölnlycke Health Care AB
Imbed Biosciences
Next Science
B. Braun Melsungen AG
Lohmann & Rauscher
"The quality of research they have done for us has been excellent..."